The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01951729 |
|
Recruitment Status :
Completed
First Posted : September 27, 2013
Last Update Posted : May 25, 2018
|
Sponsor:
Washington University School of Medicine
Collaborator:
American Diabetes Association
Information provided by (Responsible Party):
Washington University School of Medicine
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | May 2015 |
| Actual Study Completion Date : | May 2015 |